1. Home
  2. CNTB

as 12-18-2024 9:48am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Founded: 2012 Country:
United States
United States
Employees: N/A City: N/A
Market Cap: 65.5M IPO Year: 2021
Target Price: $8.00 AVG Volume (30 days): 31.2K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.39 EPS Growth: N/A
52 Week Low/High: $0.77 - $2.66 Next Earning Date: 09-05-2024
Revenue: $24,116,000 Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 63.90%

CNTB Daily Stock ML Predictions

Share on Social Networks: